Rotational thromboelastometry (ROTEM
gestational diabetes mellitus
haemostasis
hypercoagulable
pregnancy
rotational thromboelastometry
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
pubmed:
8
1
2022
medline:
23
6
2022
entrez:
7
1
2022
Statut:
ppublish
Résumé
Rotational thromboelastometry (ROTEM The aim of this study was to assess the combined effect of pregnancy and GDM on coagulation using ROTEM Ethics approval was granted for recruitment of women presenting for elective caesarean delivery. Women with pre-existing conditions affecting coagulation were excluded. Group N included health pregnant women at term and Group G included pregnant women at term with GDM. Data regarding GDM management and glycaemic control were collected. Poor glycaemic control was defined by markers of accelerated fetal growth and elevated fasting or postprandial blood glucose levels. The ROTEM There were 75 women in Group N and 21 women in Group G. Mean age and median body mass index values were comparable for both groups. There were no statistical differences found between the EXTEM and FIBTEM parameters analysed for the two groups. There was no association between GDM and increased hypercoagulability as demonstrated by ROTEM
Sections du résumé
BACKGROUND
Rotational thromboelastometry (ROTEM
AIM
The aim of this study was to assess the combined effect of pregnancy and GDM on coagulation using ROTEM
MATERIALS AND METHODS
Ethics approval was granted for recruitment of women presenting for elective caesarean delivery. Women with pre-existing conditions affecting coagulation were excluded. Group N included health pregnant women at term and Group G included pregnant women at term with GDM. Data regarding GDM management and glycaemic control were collected. Poor glycaemic control was defined by markers of accelerated fetal growth and elevated fasting or postprandial blood glucose levels. The ROTEM
RESULTS
There were 75 women in Group N and 21 women in Group G. Mean age and median body mass index values were comparable for both groups. There were no statistical differences found between the EXTEM and FIBTEM parameters analysed for the two groups.
CONCLUSIONS
There was no association between GDM and increased hypercoagulability as demonstrated by ROTEM
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
389-394Subventions
Organisme : Australian Society of Anaesthetists
Organisme : National Blood Authority
Organisme : University of Queensland
Organisme : The Royal Brisbane and Women's Hospital Foundation
Informations de copyright
© 2022 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Feuring M, Wehling M, Burkhardt H, Schultz A. Coagulation status in coronary artery disease patients with type II diabetes mellitus compared with non-diabetic coronary artery disease patients using the PFA-100® and ROTEM®. Platelets 2010; 21: 616-622.
Yürekli BPS, Özcebe OI, Kirazli S, Gürlek A. Global assessment of the coagulation status in type 2 diabetes mellitus using rotation thromboelastography. Blood Coagul Fibrinolysis 2006; 17: 545-549.
Li X, Weber NC, Cohn DM, et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J Clin Med 2021; 10: 2419.
Muche AA, Olayemi OO, Gete YK. Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia. BMC Pregnancy Childbirth 2020; 20: 1-13.
Dong C, Gu X, Chen F, et al. The variation degree of coagulation function is not responsible for extra risk of hemorrhage in gestational diabetes mellitus. J Clin Lab Anal 2020; 34: e23129.
Teliga-Czajkowska J, Sienko J, Zareba-Szczudlik J, et al. Influence of glycemic control on coagulation and lipid metabolism in pregnancies complicated by pregestational and gestational diabetes mellitus. Adv Exp Med Biol 2019; 1176: 81-88.
Teliga-Czajkowska J, Zareba-Szczudlik J, Malinowska-Polubiec A, et al. The impact of glycemic control in pregnant women with gestational and pregestational diabetes on coagulation status and lipid metabolism. Res Prac Thromb Haemost 2019; 3: 885-886.
Ye Y, Vattai A, Zhang X, et al. Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. Int J Mol Sci 2017; 18: 1651.
Gumus II, Kargili A, Karakurt F, et al. Levels of thrombin activatable fibrinolysis inhibitor in gestational diabetes mellitus. Gynecol Endocrinol 2013; 29: 327-330.
Katz D, Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth 2015; 115: ii75-ii88.
Sharma S, Uprichard J, Moretti A, et al. Use of thromboelastography to assess the combined role of pregnancy and obesity on coagulation: A prospective study. Int J Obstet Anesth 2013; 22: 113-118.
Pöyhönen-Alho M, Kaaja R. Nocturnal variability of coagulation in gestational diabetes. Thromb Res 2011; 127: S125-S126.
Queensland Health. Maternity and neonatal clinical guidelines: Gestational diabetes mellitus. Queensland Clinical Guidelines. 2015 [Cited 2021 August 1]. Available from: https://www.health.qld.gov.au/__data?assets/pdf_file/0023/140099/g-gdm.pdf.
Xie X, Wang M, Lu Y, et al. Thromboelastography (TEG) in normal pregnancy and its diagnostic efficacy in patients with gestational hypertension, gestational diabetes mellitus, or preeclampsia. J Clin Lab Anal 2021; 35: e23623.
Nankervis A, McIntyre H, Moses R, Ross G, Callaway L, Porter C et al. ADIPS Consensus guidelines for the testing and diagnosis of hyperglycaemia in pregnancy in Australia and New Zealand [Internet]. 2014 [Cited 2021 November 8]. Available from: https://www.adips.org/downloads/2014ADIPSGDMGuidelinesV18.11.2014.000.pdf.
Hunt BJ. The effect of BMI on haemostasis: Implications for thrombosis in women's health. Thromb Res 2017; 151: S53-S55.
Morgan ES, Wilson E, Melody T, et al. An observational study of haemostatic changes, leptin and soluble endoglin during pregnancy in women with different BMIs. Blood Coagul Fibrinolysis 2017; 28: 50-55.
Campello E, Spiezia L, Zabeo E, et al. Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients. Thromb Res 2015; 135: 548-553.
Kornblith LZ, Howard B, Kunitake R, et al. Obesity and clotting: Body mass index independently contributes to hypercoagulability after injury. J Trauma Acute Care Surg 2015; 78: 30-36.
De Pergola G, Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest 2002; 25: 899-904.
Urias DS, Williams P, Silvis J, et al. Using ROTEM® to evaluate the relationship between obesity and hypercoagulability. are we doing enough? Surg Endosc 2018; 32: S9.
Taura P, Rivas E, Martinez-Palli G, et al. Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery. Surg Endosc 2014; 28: 543-551.
Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guideline for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol 2014; 55: e1-29.
Lee J, Eley V, Wyssusek K, et al. Baseline parameters for rotational thromboelastometry (ROTEM®) in healthy women undergoing elective caesarean delivery: a prospective observational study in Australia. Int J Obstet Anesth 2019; 38: 10-18.
Patnaik MM, Haddad T, Morton CT. Pregnancy and thrombophilia. Expert Rev Cardiovasc Ther 2007; 5: 753-765.
Singhal D, Smorodinsky E, Guo L. Differences in coagulation among Asians and Caucasians and the implication for reconstructive microsurgery. J Recon Microsurg 2011; 27: 057-62.
Iwade M, Iwade K, Nomura M, Ozaki M. Differences in perioperative coagulation between Japanese and other ethnic groups undergoing laparoscopic cholecystectomy. Surg Endosc 2003; 17: 2012-2015.
Cheung Y-F, Chay G, Ma E. Ethnic differences in coagulation factor abnormalities after the Fontan procedure. Pediatr Cardiol 2006; 27: 96-101.
Liu Y, Sun X, Tao J, et al. Gestational diabetes mellitus is associated with antenatal hypercoagulability and hyperfibrinolysis: a case control study of Chinese women. J Matern Fetal Neonatal Med 2020; 33: 1-4.
Sucker C, Tharra K, Litmathe J, et al. Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception. Perfusion 2011; 26: 334-340.
Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, et al. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 2010; 110: 987-994.